Computational optimisation of targeted DNA sequencing for cancer detection

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Martinez, Pierre ^a   McGranahan, Nicholas ^a   Birkbak, Nicolai Juul ^b   Gerlinger, Marco ^a,c   Swanton, Charles ^a,d  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

BIOLOGY; CANCER STAGING; CHEMISTRY; COHORT ANALYSIS; DNA SEQUENCE; GENETIC DATABASE; GENETICS; HIGH THROUGHPUT SEQUENCING; HUMAN; METABOLISM; MUTATION RATE; NEOPLASMS; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR EMBOLISM;

COHORT STUDIES; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; DNA, NEOPLASM; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MUTATION RATE; NEOPLASM STAGING; NEOPLASMS; NEOPLASTIC CELLS, CIRCULATING; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA;

EID: 84890250764     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep03309     Document Type: Article

References (34)

1. Varela, I. et al. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature 469, 539-542, doi:10.1038/ nature09639 (2011).
2. The Cancer Genome Atlas Research, N. Integrated genomic analyses of ovarian carcinoma. Nature 474, 609-615, doi:10.1038/nature10166 (2011).
3. Fujimoto, A. et al.Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat. Genet. 44, 760-764, doi:10.1038/ng.2291 (2012).
4. Chapman, M. A. et al. Initial genome sequencing and analysis of multiple myeloma. Nature 471, 467-472, doi:10.1038/nature09837 (2011).
5. Gonzalez-Perez, A. & Lopez-Bigas, N. Functional impact bias reveals cancer drivers. Nucleic Acids Res. 40, e169-e169, doi:10.1093/nar/gks743 (2012).
6. Stepanenko, A. A., Vassetzky, Y. S. & Kavsan, V. M. Antagonistic functional duality of cancer genes. Gene doi:10.1016/j.gene.2013.07.047 (2013).
7. Gerlinger, M. et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366, 883-892, doi:10.1056/ NEJMoa1113205 (2012).
8. Greaves, M. & Maley, C. C. Clonal evolution in cancer. Nature 481, 306-313, doi:10.1038/nature10762 (2012).
9. Landau, Dan A. et al. Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia. Cell 152, 714-726, doi:10.1016/j.cell.2013.01.019 (2013).
10. Nik-Zainal, S. et al. The life history of 21 breast cancers. Cell 149, 994-1007, doi:10.1016/j.cell.2012.04.023 (2012).
11. Gerlinger, M. & Swanton, C. How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine. Br. J. Cancer 103, 1139-1143, doi:10.1038/sj.bjc.6605912 (2010).
12. Martinez, P. et al. Parallel evolution of tumour subclones mimics diversity between tumours. J. Pathol. 230, 356-364, doi:10.1002/path.4214 (2013).
13. Dennis Lo, Y. & Chiu, R. W. Plasma nucleic acid analysis by massively parallel sequencing: pathological insights and diagnostic implications. J. Pathol. 225, 318-323, doi:10.1002/path.2960 (2011).
14. Dawson, S.-J. et al. Analysis of circulating tumor DNA to monitor metastatic breast cancer. N. Engl. J. Med. 368, 1199-1209, doi:10.1056/ NEJMoa1213261 (2013).
15. Forshew, T. et al. Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. Sci. Transl. Med. 4, 136ra168-136ra168, doi:10.1126/scitranslmed.3003726 (2012).
16. Murtaza, M. et al. Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature doi:10.1038/nature12065 (2013).
17. Crowley, E., Di Nicolantonio, F., Loupakis, F. & Bardelli, A. Liquid biopsy: monitoring cancer-genetics in the blood. Nat. Rev. Clin. Oncol. doi:10.1038/ nrclinonc.2013.110 (2013).
18. Sozzi, G. et al. Quantification of free circulating DNA as a diagnostic marker in lung cancer. J. Clin. Oncol. 21, 3902-3908, doi:10.1200/jco.2003.02. 006 (2003). (Pubitemid 46606202)
19. Diaz, L. A. et al. The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers. Nature 486, 537-540, doi:10.1038/nature11219 (2012).
20. Misale, S. et al. Emergence of KRAS mutations and acquired resistance to anti- EGFR therapy in colorectal cancer. Nature 486, 532-536, doi:10.1038/ nature11156 (2012).
21. Garc?a-Olmo, D. C., Picazo, M. G., Toboso, I., Asensio, A. I. & Garc?a-Olmo, D. Quantitation of cell-free DNA and RNA in plasma during tumor progression in rats. Mol. Cancer 12, 8-8, doi:10.1186/1476-4598-12-8 (2013).
22. Perkins, G. et al. Multi-purpose utility of circulating plasma DNA testing in patients with advanced cancers. PLoS One 7, e47020-e47020, doi:10.1371/ journal.pone.0047020 (2012).
23. Mouliere, F. et al. Circulating Cell-Free DNA from Colorectal Cancer Patients May Reveal High KRAS or BRAF Mutation Load. Transl. Oncol. 6, 319-328 (2013).
24. Bashashati, A. et al. Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling. J. Pathol. doi:10.1002/path.4230 (2013).
25. Alexandrov, L. B., Nik-Zainal, S., Wedge, D. C., Campbell, P. J. & Stratton, M. R. Deciphering signatures of mutational processes operative in human cancer. Cell Rep. 3, 246-259, doi:10.1016/j.celrep.2012.12.008 (2013).
26. Ferlay, J. et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 127, 2893-2917, doi:10.1002/ijc.25516 (2010).
27. Jhiang, S. M. The RET proto-oncogene in human cancers. Oncogene 19, 5590-5597, doi:10.1038/sj.onc.1203857 (2000).
28. Sato, Y. et al. Integrated molecular analysis of clear-cell renal cell carcinoma. Nat. Genet. 45, 860-867, doi:10.1038/ng.2699 (2013).
29. Bullock, A. N. & Fersht, A. R. Rescuing the function of mutant p53. Nat. Rev. Cancer 1, 68-76, doi:10.1038/35094077 (2001). (Pubitemid 33741882)
30. Vogelstein, B. et al. Cancer genome landscapes. Science 339, 1546-1558, doi:10.1126/science.1235122 (2013).
31. Kinde, I., Wu, J., Papadopoulos, N., Kinzler, K. W. & Vogelstein, B. Detection and quantification of rare mutations with massively parallel sequencing. Proc. Natl. Acad. Sci. U. S. A. 108, 9530-9535, doi:10.1073/pnas. 1105422108 (2011).
32. Hiatt, J. B., Pritchard, C. C., Salipante, S. J., O'Roak, B. J. & Shendure, J. Single molecule molecular inversion probes for targeted, high-accuracy detection of lowfrequency variation. Genome Res. 23, 843-854, doi:10.1101/gr.147686.112 (2013).
33. Wang, K., Li, M. & Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38, e164-e164, doi:10.1093/nar/gkq603 (2010).
34. Sherry, S. T. et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 29, 308-311 (2001). (Pubitemid 32054478)